Transient protein-losing hypertrophic gastropathy with similarity to Ménétrier’s disease is described. Acute infection with cytomegalovirus (CMV) could be shown to play a causative role. Immunodeficiency was ruled out. The 34-year-old patient had complete resolution of the disease without antiviral treatment. To our knowledge the present report is the first case of CMV-associated protein-losing hypertrophic gastropathy in an immunocompetent adult. To date, a similar disorder has only been described in children. CMV infection should be considered in patients with acute and symptomatic protein loss of gastrointestinal origin.

Journal Section:
Case Report
Keywords:
Hypertrophic gastropathy, Protein-losing enteropathy, Cytomegalovirus
1.
Wolfson HC, Carpenter HA, Tally NJ: Ménétrier’s disease: A form of hypertrophic gastropathy or gastritis? Gastroenterology 1993;104:1310–1319.
[PubMed]
2.
Ueda M, Yasuda Y, Ueno T, Kawakami K, Honda Y, Takeda R: A case of Ménétrier’s disease accompanied by severe hypogammaglobulinemia. Am J Gastroenterol 1980;74:346–351.
[PubMed]
3.
Schulz J, Kohler B, Wegener K, Tiemann JF: Ménétrier’s disease – A rare cause of protein deficiency syndrome (in German). Dtsch Med Wochenschr 1992;117:531–534.
[PubMed]
4.
Larsen B, Tarp U, Kristensen E: Familial giant hypertrophic gastritis (Ménétrier’s disease). Gut 1987;28:1517–1521.
[PubMed]
5.
Cheung AN, Ng IO: Cytomegalovirus infection of the gastrointestinal tract in non-AIDS patients. Am J Gastroenterol 1993;88:1882–1886.
[PubMed]
6.
Suravicz CM, Myerson D: Self-limited cytomegalovirus colitis in immunocompetent individuals. Gastroenterology 1988;94:194–199.
[PubMed]
7.
Spiller RC, Lovell D, Silk DBA: Adult acquiered cytomegalovirus infection with gastric and duodenal ulceration. Gut 1988;29:1109–1111.
[PubMed]
8.
Yoshida M, Kutsumi H, Kinoshita Y, Fujita T, Soga T, Nishimura K, Kawabata K, Kawanami C, Chiba T, Fujimoto S: Cytomegalovirus enteritis in a nonimmunocompromised host: Usefulness of polymerase chain reaction by using paraffin-embedded biopsy specimen for the diagnosis. Gastrointest Endosc 1996;44:482–485.
[PubMed]
9.
Nakase H, Itani T, Mimura J, Takeuchi R, Kawasaki T, Komori H, Hashimoto K, Chiba T: Transient protein-losing enteropathy associated with cytomegalovirus infection in a noncompromised host: A case report. Am J Gastroenterol 1998;93:1005–1006.
[PubMed]
10.
Ricci S, Bonucci A, Fabiani E, Catassi C, Carlucci A, Bearzi I, Giorgi PL: Protein-losing gastroenteropathy (Ménétrier’s disease) in childhood: A report of 3 cases (in Italian). Pediatr Med Chir 1996;18(3):269–273.
11.
Eisenstat DD, Griffiths AM, Cutz E, Petric M, Drumm B: Acute cytomegalovirus infection in a child with Ménétrier’s disease. Gastroenterology 1995;109:592–595.
[PubMed]
12.
Burell M, Avella J, Gryboski J, Ablow R: Transient hypertrophic gastropathy in childhood: A protein-losing gastropathy distinct from Ménétrier’s disease. Am J Gastorenterol 1979;72:458–464.
13.
Bayerdorffer E, Ritter MM, Hatz R, Brooks W, Ruckdeschel G, Stolte M: Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori – Is Helicobacter pylori a pathogenic factor in Ménétrier’s disease. Gut 1994;35:701–704
[PubMed]
14.
Strygler B, Nicar FMJ, Santangelo WC, Porter JL, Fordtran JS: Alpha 1 antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology 1990;99:1380.
[PubMed]
15.
Bradburn DM, Redwood N, Venales CW, Gunn A: Medical therapy of Ménétrier’s disease with omeprazole. Digestion 1992;52:204–208.
[PubMed]
© 2000 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2000
You do not currently have access to this content.